Samvardhana Motherson International Employee Stock Options

Samvardhana Motherson International Legal & Regulatory

Motherson paid a ₹0.36 Crore FEMA compounding fee to RBI for unregistered 2007 bonus shares held by foreign shareholders. No material financial or operational impact.

Value

₹0.36 Cr

Samvardhana Motherson International Legal & Regulatory

Samvardhana Motherson's US subsidiary received a Notice of Penalty Rescission, revoking a USD 19,500 penalty from the New York State Workers' Compensation Board after its appeal. The company is updating its 14 October 2026 disclosure.

Value

₹0.19 Cr

Samvardhana Motherson International Acquisition

NCLT Mumbai approved amalgamation of three wholly-owned subsidiaries into Samvardhana Motherson International. No consideration as all entities are wholly-owned; no change in listed entity shareholding.

Samvardhana Motherson International Merger & Restructuring

The NCLT Mumbai Bench approved a composite scheme of arrangement involving four Motherson entities, including a demerger and amalgamations with wholly owned subsidiaries. The excerpt states no transaction value.

Samvardhana Motherson International Debt & Borrowing

Samvardhana Motherson filed its half-yearly statement of outstanding NCDs and CPs for April–September 2026. The filing covers four active debt tranches with stated maturity and coupon details.

Samvardhana Motherson International Other Announcement

Samvardhana Motherson International Limited has intimated details of its Compliance Officer and RTA pursuant to SEBI Listing Regulations, 2015 for the half-year ended September 30, 2026.

Aye Finance Employee Stock Options

Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.

Aarti Pharmalabs Employee Stock Options

Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.

OnEMI Technology Solutions Employee Stock Options

OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.

Bliss GVS Pharma Employee Stock Options

Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.

Bandhan Bank Employee Stock Options

Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.

Maxvolt Energy Industries Employee Stock Options

Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.

Execution

Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date